This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Nottingham. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Jiaxin Chua: Innovator in Cancer Research
Introduction
Jiaxin Chua is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of cancer research through his innovative work on glycans. His research focuses on the potential of glycans as functional cancer targets, which could lead to advancements in cancer treatment.
Latest Patents
Jiaxin Chua holds a patent titled "Glycans as functional cancer targets and antibodies thereto." This patent describes a glycan with the structure galβ1-3GlcNacβ1-3Galβ1-4(Fucα1-3)GlcNAc (LecLe), which is attached to a lipid or protein backbone. The patent also includes isolated binding members capable of binding to this glycan, highlighting its potential applications in cancer therapies. He has 1 patent to his name.
Career Highlights
Chua is affiliated with the University of Nottingham, where he conducts his research. His work has garnered attention for its innovative approach to targeting cancer cells, which could pave the way for new therapeutic strategies.
Collaborations
Jiaxin collaborates with esteemed colleagues, including Tina Parsons and Lindy Gillian Durrant. These partnerships enhance the research environment and contribute to the advancement of cancer research.
Conclusion
Jiaxin Chua's contributions to cancer research through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to impact cancer treatment significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile